Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.

Article  CAS  PubMed  Google Scholar 

Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395(10231):1208–16.

Article  CAS  PubMed  Google Scholar 

Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, et al. Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate Cancer: a prospective single-arm clinical trial. JAMA Oncol. 2019;5(6):856–63.

Article  PubMed  PubMed Central  Google Scholar 

Eiber M, Maurer T, Souvatzoglou M, Beer AJ, Ruffani A, Haller B, et al. Evaluation of hybrid (6)(8)Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med. 2015;56(5):668–74.

Article  PubMed  Google Scholar 

Mesters JR, Barinka C, Li W, Tsukamoto T, Majer P, Slusher BS, et al. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. EMBO J. 2006;25(6):1375–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robinson MB, Blakely RD, Couto R, Coyle JT. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. J Biol Chem. 1987;262(30):14498–506.

Article  CAS  PubMed  Google Scholar 

Blakely RD, Ory-Lavollee L, Thompson RC, Coyle JT. Synaptosomal transport of radiolabel from N-acetyl-aspartyl-[3H]glutamate suggests a mechanism of inactivation of an excitatory neuropeptide. J Neurochem. 1986;47(4):1013–9.

Article  CAS  PubMed  Google Scholar 

Li X, Rowe SP, Leal JP, Gorin MA, Allaf ME, Ross AE, et al. Semiquantitative parameters in PSMA-Targeted PET imaging with (18)F-DCFPyL: variability in Normal-Organ Uptake. J Nucl Med. 2017;58(6):942–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA, et al. PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging. 2013;40(4):486–95.

Article  CAS  PubMed  Google Scholar 

Langbein T, Wurzer A, Gafita A, Robertson A, Wang H, Arcay A, et al. The influence of specific activity on the Biodistribution of (18)F-rhPSMA-7.3: a retrospective analysis of clinical PET Data. J Nucl Med. 2022;63(5):742–5.

CAS  PubMed  Google Scholar 

Armstrong WR, Gafita A, Zhu S, Thin P, Nguyen K, Alano R, et al. The impact of Monosodium Glutamate on (68)Ga-PSMA-11 Biodistribution in men with prostate Cancer: a prospective Randomized, Controlled Imaging Study. J Nucl Med. 2021;62(9):1244–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rahbar K, Afshar-Oromieh A, Seifert R, Wagner S, Schafers M, Bogemann M, et al. Do fasting or high caloric drinks affect the physiological uptake of fluorine-18 prostate-specific membrane antigen-1007 in liver and bowel? World J Nucl Med. 2020;19(3):220–3.

Article  PubMed  Google Scholar 

Wondergem M, van der Zant FM, Vlottes PW, Knol RJJ. Effects of Fasting on (18)F-DCFPyL uptake in prostate Cancer lesions and tissues with known high physiologic uptake. J Nucl Med. 2018;59(7):1081–4.

Article  CAS  PubMed  Google Scholar 

Mohan V, Bruin NM, van de Kamer JB, Sonke JJ, Vogel WV. The effect of eating on the uptake of PSMA ligands in the salivary glands. EJNMMI Res. 2021;11(1):95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gafita A, Wang H, Robertson A, Armstrong WR, Zaum R, Weber M, et al. Tumor Sink Effect in (68)Ga-PSMA-11 PET: myth or reality? J Nucl Med. 2022;63(2):226–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wurzer A, Di Carlo D, Schmidt A, Beck R, Eiber M, Schwaiger M, et al. Radiohybrid ligands: a Novel Tracer Concept Exemplified by (18)F- or (68)Ga-Labeled rhPSMA inhibitors. J Nucl Med. 2020;61(5):735–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kroenke M, Wurzer A, Schwamborn K, Ulbrich L, Jooss L, Maurer T, et al. Histologically confirmed diagnostic efficacy of (18)F-rhPSMA-7 PET for N-Staging of patients with primary high-risk prostate Cancer. J Nucl Med. 2020;61(5):710–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eiber M, Kroenke M, Wurzer A, Ulbrich L, Jooss L, Maurer T, et al. (18)F-rhPSMA-7 PET for the detection of biochemical recurrence of prostate Cancer after Radical Prostatectomy. J Nucl Med. 2020;61(5):696–701.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gallavan RH Jr., Chou CC. Possible mechanisms for the initiation and maintenance of postprandial intestinal hyperemia. Am J Physiol. 1985;249(3 Pt 1):G301–8.

CAS  PubMed  Google Scholar 

Chou CC. Splanchnic and overall cardiovascular hemodynamics during eating and digestion. Fed Proc. 1983;42(6):1658-61.

Madsen JL, Sondergaard SB, Moller S. Meal-induced changes in splanchnic blood flow and oxygen uptake in middle-aged healthy humans. Scand J Gastroenterol. 2006;41(1):87–92.

Article  PubMed  Google Scholar 

Gallavan RH Jr., Chou CC, Kvietys PR, Sit SP. Regional blood flow during digestion in the conscious dog. Am J Physiol. 1980;238(2):H220–5.

PubMed  Google Scholar 

Chou CC, Grassmick B. Motility and blood flow distribution within the wall of the gastrointestinal tract. Am J Physiol. 1978;235(1):H34–9.

CAS  PubMed  Google Scholar 

Siregar H, Chou CC. Relative contribution of fat, protein, carbohydrate, and ethanol to intestinal hyperemia. Am J Physiol. 1982;242(1):G27–31.

CAS  PubMed  Google Scholar 

Jochumsen MR, Sorensen J, Tolbod LP, Pedersen BG, Frokiaer J, Borre M, et al. Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness. EJNMMI Res. 2021;11(1):12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Dongen AJ, van Rijk PP. Minimizing liver, bowel, and gastric activity in myocardial perfusion SPECT. J Nucl Med. 2000;41(8):1315–7.

PubMed  Google Scholar 

Emmett L, Willowson K, Violet J, Shin J, Blanksby A, Lee J, Lutetium. (177) PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy. J Med Radiat Sci. 2017;64(1):52–60.

Mahajan S, Grewal RK, Friedman KP, Schoder H, Pandit-Taskar N. Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: current concepts in imaging and management. Transl Oncol. 2022;21:101445.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feuerecker B, Tauber R, Knorr K, Heck M, Beheshti A, Seidl C, et al. Activity and adverse events of actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant prostate Cancer after failure of Lutetium-177-PSMA. Eur Urol. 2021;79(3):343–50.

Article  CAS  PubMed  Google Scholar 

Heynickx N, Herrmann K, Vermeulen K, Baatout S, Aerts A. The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: a review of the lessons learnt so far. Nucl Med Biol. 2021;98–9:30–9.